Publikationen
| Jahr | Publikation |
| 2021 | Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T, Majek O, Muzik J, Nilbert MC, Tybjerg AJ, Innos K, Mägi M, Malila N, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Katalinic A, Walsh PM, Senore C, Rosso S, Vincerzevskiene I, Lemmens V, Elferink MAG, Johannesen TB, Korner H, Pfeffer F, Bento MJ, Rodrigues J, Alves da Costa F, Miranda A, Zadnik V, Zagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Chirlaque MD, Ballesta M, Sundquist K, Sundquist J, Weber M, Jordan A, Herrmann C, Mousavi M, Ryzhov A, Hoffmeister M, Brenner H. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021. |
| 2021 | Garbe C, Keim U, Gandini S, Amaral T, Katalinic A, Hollezcek B, Martus P, Flatz L, Leiter U, Whiteman D. Eur J Cancer. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. 2021 May 29;152:18-25. |
| 2021 | Pruessmann J, Pursche T, Hammersen F, Katalinic A, Fischer D, Waldmann A. Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes. Breast care (Basel, Switzerland). 2021;16(2):163-72 |
| 2021 | Sacchetto L, Rosso S, Comber H, Bouchardy C, Broganelli P, Galceran J, Hackl M, Katalinic A, Louwman M, Robsahm TE, Tryggvadottir L, Tumino R, Van Eycken E, Walsh PM, Zadnik V, Zanetti R. Skin melanoma deaths within 1 or 3?years from diagnosis in Europe. Int J Cancer. 2021 |
| 2020 | Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen. 2020;82(S 01):62-71. |
| 2020 | Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. Long-term relative survival from melanoma in Germany 1997-2013. Melanoma Res. 2020;30(4):386-95. |
| 2020 | Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer. Breast Care. 2020;15(2):163-70. |
| 2020 | Hübner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term Incidence and Mortality Trends for Breast Cancer in Germany. Geburtsh Frauenheilk. 2020;80(6):611-8. |
| 2020 | Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, Emrich K, Kajüter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H. Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States. Cancers (Basel). 2020;12(9). |
| 2020 | Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, Carmona-Garcia M, Rodriguez-Barranco M, Vanschoenbeek K, Rapiti E, Katalinic A, Marcos-Gragera R, Van Eycken L, Sanchez MJ, Bielska-Lasota M, Rossi PG, Sant M. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study. Eur J Surg Oncol. 2020;46(6):1151-9. |
| 2020 | Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. 2020. |
| 2020 | Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, Eberle A, Holleczek B, Jansen L, Brenner H. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study. Int J Cancer. 2020. |
| 2019 | Garbe C, Keim U, Eigentler TK, Amaral T, Katalinic A, Holleczek B, Martus P, Leiter U. Time trends in incidence and mortality of cutaneous melanoma in Germany. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019;33(7):1272-80. |
| 2019 | Hübner J, Hübner F, Terheyden P, Katalinic A. [Turning point in skin cancer mortality : An analysis of the trend in Germany from 1998 to 2017]. Hautarzt. 2019;70(12):989-92. |
| 2019 | Hübner J, Lewin P, Pritzkuleit R, Eisemann N, Maier W, Katalinic A. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts. Int J Colorectal Dis. 2019;34(4):599-605. |
| 2019 | Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2019. |
| 2019 | Rudolph C, Petersen GS, Pritzkuleit R, Storm H, Katalinic A. The acceptance and applicability of a patient-reported experience measurement tool in oncological care: a descriptive feasibility study in northern Germany. BMC Health Serv Res. 2019;19(1):786. |
| 2019 | Rudolph CES, Katalinic A. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects]. Gesundheitswesen. 2019;81:993-1000. |
| 2018 | Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. J Med Screen. 2018;25(3):166-8. |
| 2018 | Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K, Brenner H, Workgroup GCS. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral oncology. 2018;76:8-15. |
| 2018 | Pulte D, Weberpals J, Schroder CC, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Jansen L, Brenner H. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century. Int J Cancer. 2018;143(2):324-32. |
| 2017 | Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries. Int J Cancer. 2017;141(11):2270-80. |
| 2017 | Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Scheufele R, Wirth MP, Huber J. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study. Prostate Cancer Prostatic Dis. 2017;20(1):61-6. |
| 2017 | Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma. Br J Cancer. 2017;116(2):253-9. |
| 2017 | Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, Garbe C. Incidence, Mortality and Trends of Non-Melanoma Skin Cancer in Germany. J Invest Dermatol. 2017;137(9):1860-7. |
| 2017 | Pritzkuleit R, Katalinic A, Gieseler F. Krebsregister und Gesundheitswesen. Anfragen bei Verdacht auf Krebshäufungen, Erwartungen und Befürchtungen. Onkologe. 2017;23(4). |
| 2017 | Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H. Survival for patients with rare haematologic malignancies: Changes in the early 21st century. Eur J Cancer. 2017;84:81-7. |
| 2017 | Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States in the early 21st century. Haematologica. 2017;102(6):e229-e32. |
| 2016 | Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L, GEKID Cancer Survival Workgroup. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. Eur J Cancer. 2016;52:102-8. |
| 2016 | Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining Bowel Cancer Incidence and Mortality in Germany. Dtsch Ärztebl Int. 2016;113(7):101-6. |
| 2016 | Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, Gekid Cancer Survival Working Group. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries. Sci Rep. 2016;6:22084. |
| 2016 | Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, Group GCSW. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol. 2016;174(4):778-85. |
| 2016 | Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy. Hematol Oncol. 2016;34(2):93-101. |
| 2016 | Heywang-Kobrunner SH, Schreer I, Hacker A, Noftz MR, Katalinic A. Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS). Eur Radiol. 2016;26(2):342-50. |
| 2016 | Katalinic A. Improved prognosis for symptom-free older women with mammography-detected breast cancer? Strahlenther Onkol. 2016;192(2):130-2. |
| 2016 | Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H, GEKID Cancer Survival Working Group and the DRST. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation. Eur J Cancer. 2016;62:1-8. |
| 2016 | Peller M, Katalinic A, Wollenberg B, Teudt IU, Meyer JE. Epidemiology of laryngeal carcinoma in Germany, 1998-2011. Eur Arch Otorhinolaryngol. 2016;273(6):1481-7. |
| 2016 | Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 2016;9(1):28. |
| 2016 | Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. Int J Cancer. 2016;139(6):1289-96. |
| 2016 | Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States. Pancreas. 2016;45(6):908-14. |
| 2015 | Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with gastric lymphoma in Germany and in the United States. J Gastroenterol Hepatol. 2015;30(10):1485-91. |
| 2015 | Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A, Eisemann N, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki K, Group GCSW. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer letters. 2015;369(1):152-66. |
| 2015 | Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, Group GSW. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung cancer. 2015;90(3):528-33. |
| 2015 | Gebauer J, Fick EM, Waldmann A, Langer T, Kreitschmann-Andermahr I, Lehnert H, Katalinic A, Brabant G. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma - a registry based study in Northern Germany. Eur J Endocrinol. 2015;173(2):139-48. |
| 2015 | Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer. 2015;136(11):2649-58. |
| 2015 | Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 2015. |
| 2015 | Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. 2015;13(8):788-97. |
| 2015 | Sant M, Chirlaque Lopez MD, Agresti R, Sanchez Perez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larranaga N, Rossi S, Siesling S, Minicozzi P, Group E-W. Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study. Eur J Cancer. 2015. |
| 2015 | Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Hollander NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2015;51(9):1188-98. |
| 2014 | Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134(1):8. |
| 2014 | Eisemann N, Waldmann A, Katalinic A. Inzidenz des malignen Melanoms und Veränderung der stadienspezifischen Inzidenz nach Einführung eines Hautkrebsscreenings in Schleswig-Holstein. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(1):7. |
| 2014 | Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H, GEKID Cancer Survival Working Group. Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer. 2014;134(12):2951-60. |
| 2014 | Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century. Br J Haematol. 2014;164(6):851-7. |
| 2014 | Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014;9(1):e85554. |
| 2014 | Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Holländer NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2014. |
| 2013 | Eisemann N, Waldmann A, Katalinic A. Epidemiology of Breast Cancer – Current Figures and Trends. Geburtsh Frauenheilk. 2013;73(2):130–5. |
| 2013 | Katalinic A, Richter A, Babaev V, Pritzkuleit R. Krebsregistrierung im europäischen und nichteuropäischen Ausland. Was können wir lernen? Onkologe. 2013;19:1025–36 |
| 2013 | Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, Katalinic A, Gondos A, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8(1):e53415. |
| 2013 | Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H, GEKID Cancer Survival Working Group. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. 2013;2(5):718-24. |
| 2013 | Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One. 2013;8(7):e68077. |
| 2013 | Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A, Network of German Cancer Registries (GEKID). Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol. 2013;37(4):370-3. |
| 2013 | Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. Cancer Epidemiol. 2013;37(4):492-7. |
| 2013 | Waldmann A, Eisemann N, Katalinic A. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours – Current Data and Epidemiological Trends. Geburtsh Frauenheilk. 2013;73(2):123–9. |
| 2012 | Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201-11. |
| 2012 | Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H. Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage. Eur J Cancer Prev. 2012;22(1):9. |
| 2012 | Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, Brenner H. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer. 2012;12(1):128. |
| 2012 | Eisemann N, Jansen L, Holleczek B, Waldmann A, Luttmann S, Emrich K, Hauschild A, Brenner H, Katalinic A, GEKID Survival Working Group. Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol. 2012;167(3):7. |
| 2012 | Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Recent trends in incidence and mortality of oral and pharyngeal cancer in Schleswig-Holstein in Northern Germany. Community Dent Health. 2012;29(4):6. |
| 2012 | Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Nennecke A, Brenner H. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncol. 2012;51:9. |
| 2012 | Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, Brenner H. Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol. 2012;27(9):5. |
| 2012 | Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart E. Does Skin Cancer Screening Save Lives? - An Observational Study Comparing Trends in Melanoma Mortality in Regions With and Without Screening. Cancer. 2012;118(21):8. |
| 2012 | Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H, Group GCSW. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up. Eur J Cancer Prev. 2012;22(3):5. |
| 2012 | Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer. 2012;106:6. |
| 2012 | Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, the GCSWG. Survival of non-Hodgkin lymphoma patients in Germany in the early 21st century Leukemia & lymphoma. 2012;54(5):7. |
| 2012 | Rusner C, Bandemer-Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, Katalinic A, Kuss O, Schmidt-Pokrzywniak A, Schubert-Fritschle G, Tillack A, Stang A. Population-based hormone receptor-specific incidence trends of breast cancer in Germany. Maturitas. 2012;73(2):6. |
| 2012 | Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: Stage-shift 6 years after implementation of a colonoscopy screening program. Cancer Epidemiol. 2012;36:4. |
| 2012 | Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, Greinert R, Volkmer B, Katalinic A. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer. 2012;106(5):5. |
| 2011 | Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database. Am J Epidemiol. 2011. |
| 2011 | Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D. Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet. 2011;284(1):169-74. |
| 2011 | Hakulinen T, Arbyn M, Brewster DH, Coebergh JW, Coleman MP, Crocetti E, Forman D, Gissler M, Katalinic A, Luostarinen T, Pukkala E, Rahu M, Storm H, Sund R, Tornberg S, Tryggvadottir L. Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health. 2011;21(6):686-7. |
| 2011 | Hentschel S, Pritzkuleit R, Schmid-Höpfner S, Katalinic A. Epidemiologische Krebsregistrierung in Deutschland. Aufgaben und aktueller Status. Onkologe. 2011;17(2). |
| 2011 | Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany. J Cancer Res Clin Oncol. 2011. |
| 2011 | Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2011. |
| 2010 | Katalinic A, Emrich K, Luttmann S, Holleczek B, Stabenow R, Urbschat I, Meyer M. Häufigkeiten, Trends und regionale Unterschiede von Krebserkrankungen in Deutschland. Prävention. 2010;33(4):99-102. |
| 2010 | Peters E, Pritzkuleit R, Beske F, Katalinic A. Demografischer Wandel und Krankheitshäufigkeiten. Eine Projektion bis 2050. Bundesgesundheitsbl. 2010;53(5):417-26. |
| 2010 | Pritzkuleit R, Beske F, Katalinic A. Demographischer Wandel und Krebserkrankungen in der Zukunft. Onkologie. 2010;33 (Suppl 7):19-24. |
| 2010 | Stang A, Katalinic A, Dieckmann KP, Pritzkuleit R, Stabenow R. A novel approach to estimate the German-wide incidence of testicular cancer. Cancer Epidemiol. 2010;34(1):13-9. |
| 2009 | Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence - Results from the German Network of Cancer Registries. Pathobiology. 2009;76(2):90-7. |
| 2009 | Katalinic A, Pritzkuleit R, Waldmann A. Recent Trends in Breast Cancer Incidence and Mortality in Germany. Breast Care. 2009;4:75-80. |
| 2009 | Pritzkuleit R, Katalinic A. Räumliche Karzinomanalyse: regionaler Vergleich der Inzidenz kolorektaler Karzinome in Bayern im Zeitraum 2006-2008. Lübeck: Institut für Krebsepidemiologie; 2009. |
| 2009 | Waldmann A, Eberle A, Hentschel S, Holleczek B, Katalinic A. Bevölkerungsbezogene Darmkrebsinzidenz im Zeitraum 2000 bis 2006 - Deuten sich erste Auswirkungen des Koloskopie-Screenings an? Eine gemeinsame Auswertung der Krebsregisterdaten aus Bremen, Hamburg, dem Saarland und Schleswig-Holstein |
| 2009 | Waldmann A, Rohde V, Bremner K, Krahn M, Küchler T, Katalinic A. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reverence men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P). BMC Cancer. 2009;9. |
| 2008 | Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2008;107(3):427-30. |
| 2008 | Pritzkuleit R, Waldmann A, Raspe H, Katalinic A. The population-based oncological health care study OVIS - Recruitment of the patients and analysis of the non-participants. BMC Cancer. 2008;8(1):311-23. |
| 2007 | Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2007. |
| 2005 | Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense HW. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording]. Gesundheitswesen 2005; 67(10):729-735. |
| 2005 | Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, Jockel KH. Incidence of Skin Lymphoma in Germany. Ann Epidemiol 2005. |
| 2004 | Gierspien K, Haartje U, Hentschel S, Katalinic A, Kieschke J. Tumorstadienverteilung in der Zielgruppe für das Mammographie-Screening. Deutsches Ärzteblatt 2004; 101(30):2117-2122. |
| 2004 | Katalinic A. Epidemiologische Krebsregistrierung in Deutschland - Bestandsaufnahme und Perspektiven. Bundesgesundheitsbl 2004; 47(5):422-428. |
| 2003 | Katalinic A, Holzmann M, Kunze U. Abhängigkeit der Tumorstadien von der Vollzähligkeit der Registrierung bei Brustkrebs in einem bevölkerungsbezogenen Krebsregister. Gesundheitswesen 2003; 65(8-9):509-515. |
| 2003 | Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (Epidemiology of skin cancer). BJD 2003;(149):1200-1206. |
